Niclosamide Prevents the Formation of Large Ubiquitin-Containing Aggregates Caused by Proteasome Inhibition

Autor: Thibault Mayor, Maria Brack, Esther A. Gies, Carolina Arias Novoa, Poul H. Sorensen, Inga B. Wilde, Aruna D. Balgi, Barak Rotblat, Jason M. Winget, Michel Roberge
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Proteasome Endopeptidase Complex
Green Fluorescent Proteins
lcsh:Medicine
Plasma protein binding
Protein aggregation
Biology
Mechanistic Target of Rapamycin Complex 1
Biochemistry
Neurological Disorders
Microtubules
Cell Biology/Cell Signaling
03 medical and health sciences
0302 clinical medicine
JUNQ and IPOD
Ubiquitin
Microtubule
Biochemistry/Cell Signaling and Trafficking Structures
Autophagy
Humans
lcsh:Science
Cell Biology/Chemical Biology of the Cell
030304 developmental biology
Sirolimus
0303 health sciences
Multidisciplinary
Antinematodal Agents
TOR Serine-Threonine Kinases
lcsh:R
Biochemistry/Chemical Biology of the Cell
Fluorescence recovery after photobleaching
Proteins
Neurodegenerative Diseases
Cell Biology
Chemical Biology/Chemical Biology of the Cell
Cell biology
Proteasome
Solubility
Multiprotein Complexes
biology.protein
Niclosamide
lcsh:Q
Lysosomes
030217 neurology & neurosurgery
Research Article
Protein Binding
Zdroj: PLoS ONE
PLoS ONE, Vol 5, Iss 12, p e14410 (2010)
ISSN: 1932-6203
Popis: Background Protein aggregation is a hallmark of many neurodegenerative diseases and has been linked to the failure to degrade misfolded and damaged proteins. In the cell, aberrant proteins are degraded by the ubiquitin proteasome system that mainly targets short-lived proteins, or by the lysosomes that mostly clear long-lived and poorly soluble proteins. Both systems are interconnected and, in some instances, autophagy can redirect proteasome substrates to the lysosomes. Principal Findings To better understand the interplay between these two systems, we established a neuroblastoma cell population stably expressing the GFP-ubiquitin fusion protein. We show that inhibition of the proteasome leads to the formation of large ubiquitin-containing inclusions accompanied by lower solubility of the ubiquitin conjugates. Strikingly, the formation of the ubiquitin-containing aggregates does not require ectopic expression of disease-specific proteins. Moreover, formation of these focused inclusions caused by proteasome inhibition requires the lysine 63 (K63) of ubiquitin. We then assessed selected compounds that stimulate autophagy and found that the antihelmintic chemical niclosamide prevents large aggregate formation induced by proteasome inhibition, while the prototypical mTORC1 inhibitor rapamycin had no apparent effect. Niclosamide also precludes the accumulation of poly-ubiquitinated proteins and of p62 upon proteasome inhibition. Moreover, niclosamide induces a change in lysosome distribution in the cell that, in the absence of proteasome activity, may favor the uptake into lysosomes of ubiquitinated proteins before they form large aggregates. Conclusions Our results indicate that proteasome inhibition provokes the formation of large ubiquitin containing aggregates in tissue culture cells, even in the absence of disease specific proteins. Furthermore our study suggests that the autophagy-inducing compound niclosamide may promote the selective clearance of ubiquitinated proteins in the absence of proteasome activity.
Databáze: OpenAIRE